Does METHYLDOPA Cause Teratogenicity? 36 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Teratogenicity have been filed in association with METHYLDOPA (Methyldopa). This represents 1.4% of all adverse event reports for METHYLDOPA.
36
Reports of Teratogenicity with METHYLDOPA
1.4%
of all METHYLDOPA reports
0
Deaths
21
Hospitalizations
How Dangerous Is Teratogenicity From METHYLDOPA?
Of the 36 reports, 21 (58.3%) required hospitalization, and 21 (58.3%) were considered life-threatening.
Is Teratogenicity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLDOPA. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLDOPA Cause?
Foetal exposure during pregnancy (1,028)
Premature baby (792)
Maternal exposure during pregnancy (623)
Premature delivery (519)
Exposure during pregnancy (502)
Low birth weight baby (350)
Foetal growth restriction (172)
Drug ineffective (162)
Live birth (153)
Off label use (152)
What Other Drugs Cause Teratogenicity?
LEVETIRACETAM (39)
DOLUTEGRAVIR (36)
LEUCOVORIN (36)
SULFAMETHOXAZOLE\TRIMETHOPRIM (36)
PREDNISONE (34)
VALGANCICLOVIR (32)
RITONAVIR (28)
EMTRICITABINE\TENOFOVIR DISOPROXIL (27)
OMEPRAZOLE (21)
SERTRALINE (20)
Which METHYLDOPA Alternatives Have Lower Teratogenicity Risk?
METHYLDOPA vs METHYLENE BLUE
METHYLDOPA vs METHYLENEDIOXYPYROVALERONE
METHYLDOPA vs METHYLERGONOVINE
METHYLDOPA vs METHYLNALTREXONE
METHYLDOPA vs METHYLPHENIDATE